Nano-X Imaging (NNOX) said Thursday that the US Food and Drug Administration has approved its Nanox.ARC X imaging system.
The company said Nanox.ARC X features its digital Nanox.SOURCE and advanced tomosynthesis technology.
The approval covers the system's production of tomographic images for general use, the company added.
Nano-X Imaging said it is set to start offering Nanox.ARC X later this year.
Price: 4.95, Change: +0.45, Percent Change: +10.00
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.